Wednesday, April 9, 2014

Celtics injury report

With five games remaining in this rebuilding year, Celtics head coach Brad Stevens he has seen how an NBA season can take a toll on the health of his players.

Such has been the case for Avery Bradley, who has sat out the last two games. Both resulted in losses, but also gave more opportunities to players such as Chris Johnson and Phil Pressey.

“That’s one thing that you can anticipate, that it’s a long grind and not an easy thing for these guys to go through,” said Stevens. “Across the league you see guys who have played well in spurts who have also struggled in spurts who are healthy or semi-healthy. You see others who have had to sit multiple games and recover from everything from nagging injuries to more serious injuries.” [Boston Herald]

Despite nursing tendinitis in his right Achilles tendon, Bradley has not missed a practice. In fact, according to associated press AB completed a 360-degree dunk during yesterday’s scrimmage. It’s fair to say he will be a go tonight at Atlanta.

Kris Humphries on the other hand did not make the trip down south with his teammates. Humphries had an MRI scheduled for his right knee after continued treatment, which also comes from the result of tendinitis. He will sit out tonight, and his return is unknown at the moment. Stevens described it as “sharp pain below his right kneecap.”

Jared Sullinger suffered a thigh contusion in Saturday night’s loss to the Detroit Pistons. He sat out of practice two days ago, but made an appearance in yesterday’s workout and shoot around. Despite his quad injury he is set to play tonight against the Hawks.

Don’t let these latest injuries fool you in to thinking any one of these players will be shutdown for the remainder of the season. Coach Stevens believes in a strong finish.

“No talk of shutting anyone down,” said Stevens. “The only way someone would be shutdown would be if they physically couldn’t participate.” [Boston Herald]

We shall see what the next week or so will hold for Stevens and company.

Joel Pavón

No comments:

Post a Comment